MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) IN PATIENTS WITH B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY AFTER NINE MONTHS OF FOLLOW-UP: A RETROSPECTIVE COHORT STUDY

被引：0
|
作者：
Gonzalez, Enrique J. Alvirez [1 ]
Daryanani, Andres E. [1 ]
Collantes-Hoyos, Diana B. [1 ]
Ricaurte-Carmona, Carolina [1 ]
Garcia, Eduardo Tellez [1 ]
Gomez, Maria [1 ]
Paludo, Jonas [1 ]
Rosenthal, Allison [1 ]
Villarraga, Hector R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1117-03
引用
收藏
页码：2376 / 2376
页数：1
相关论文
共 50 条
  • [1] Aggressive Lymphoma after CD19 CAR T-Cell Therapy
    Kobbe, Guido
    Bruggemann, Monika
    Baermann, Ben-Niklas
    Wiegand, Laura
    Trautmann, Heiko
    Yousefian, Schayan
    Libertini, Silvana
    Menssen, Hans D.
    Maier, Harald J.
    Ulrich, Peter
    Gao, Jingbo
    Bruch, Peter-Martin
    Liebers, Nora
    Radujkovic, Aleksandar
    Seifert, Marc
    Schniederjohann, Christina
    Paramasivam, Nagarajan
    Fitzgerald, Donnacha
    Seidel, Maximilian
    Esposito, Irene
    Germing, Ulrich
    Cadeddu, Ron-Patrick
    Nachtkamp, Kathrin
    Jaeger, Paul
    Ulrych, Thomas
    Fischer, Johannes C.
    Rox, Jutta M.
    Giesel, Frederik
    Koch, Raphael
    Antoch, Gerald
    Distler, Joerg H. W.
    Meuth, Sven G.
    Jacobsen, Malte
    Hubschmann, Daniel
    Lu, Junyan
    Iaccarino, Ingram
    Haas, Simon
    Damm, Frederik
    Dietrich, Sascha
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (13): : 1217 - 1226
  • [2] A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
    Gouni, Sushanth
    Rosenthal, Allison C.
    Crombie, Jennifer L.
    Ip, Andrew
    Kamdar, Manali K.
    Hess, Brian
    Feng, Lei
    Watson, Grace
    Ayers, Amy
    Neelapu, Sattva S.
    Khurana, Arushi
    Lin, Yi
    Iqbal, Madiha
    Merryman, Reid W.
    Strati, Paolo
    BLOOD ADVANCES, 2022, 6 (09) : 2757 - 2762
  • [3] CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up
    Mueller, Fabian
    Taubmann, Jule
    Bucci, Laura
    Wilhelm, Artur
    Bergmann, Christina
    Voelkl, Simon
    Aigner, Michael
    Rothe, Tobias
    Minopoulou, Ioanna
    Tur, Carlo
    Knitza, Johannes
    Kharboutli, Soraya
    Kretschmann, Sascha
    Vasova, Ingrid
    Spoerl, Silvia
    Reimann, Hannah
    Munoz, Luis
    Gerlach, Roman G.
    Schaefer, Simon
    Grieshaber-Bouyer, Ricardo
    Korganow, Anne-Sophie
    Farge-Bancel, Dominique
    Mougiakakos, Dimitrios
    Bozec, Aline
    Winkler, Thomas
    Kroenke, Gerhard
    Mackensen, Andreas
    Schett, Georg
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (08): : 687 - 700
  • [4] Secondary malignancy after CD19 CAR T-cell therapy
    Rudek, Loreen Sophie
    Alakus, Hakan
    ONKOLOGIE, 2025, : 504 - 506
  • [5] Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
    Dahiya, Saurabh
    Luetkens, Tim
    Lutfi, Forat
    Avila, Stephanie
    Iraguha, Thierry
    Margiotta, Philip
    Hankey, Kim G.
    Lesho, Patricia
    Law, Jennie Y.
    Lee, Seung T.
    Baddley, John
    Kocoglu, Mehmet
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Atanackovic, Djordje
    BLOOD ADVANCES, 2022, 6 (02) : 686 - 689
  • [6] Neuropathological autopsy findings after CD19 CAR-T- cell therapy for diffuse large B-cell lymphoma
    Champion, Samantha
    Martinez-Lage, Maria
    MODERN PATHOLOGY, 2019, 32
  • [7] Neuropathological autopsy findings after CD19 CAR-T-cell therapy for diffuse large B-cell lymphoma
    Champion, Samantha
    Martinez-Lage, Maria
    LABORATORY INVESTIGATION, 2019, 99
  • [8] Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma
    Kuipers, Maria T.
    Spanjaart, Anne M.
    Bonifazi, Francesca
    diBlasi, Roberta
    Zinzani, Pier L.
    Thieblemont, Catherine
    Baudet, Mathilde
    Biemond, Bart J.
    Kok, Wouter E. M.
    Kersten, Marie J.
    LEUKEMIA & LYMPHOMA, 2024, 65 (03) : 399 - 402
  • [9] Late adverse events in patients with aggressive B-cell lymphoma after CD19-targeted chimeric antigen receptor T-cell therapy
    Camacho Arteaga, Lina
    Leguizamo Martinez, Lina Maria
    Filippi Arriaga, Francesca
    Iacoboni Garcia-Calvo, Gloria
    Alonso Martinez, Carla
    Vidal Guitart, Xavier
    Lopez Corral, Lucia
    Perez Lopez, Estefania
    Kwon, Mi
    Bailen Almorox, Rebeca
    Hernani Morales, Rafael
    Guerreiro, Manuel
    Maiquez Asuero, Maria Pilar
    Barba Sunol, Pere
    Agusti Escasany, Antonia
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 22 - 22
  • [10] Phase 2 Study of CD19 CAR T Cells with a Fully Human Binder for Large B-Cell Lymphoma in Relapse or Progression after a Murine Binder-Bearing CD19 CAR T-Cell Therapy
    Gauthier, Jordan
    Huang, Jennifer J.
    Jaeger-Ruckstuhl, Carla
    Liang, Emily C.
    Albittar, Aya
    Portuguese, Andrew J.
    Wu, Qian
    Torkelson, Aiko
    Kirchmeier, Delaney
    Chutnik, Abigail
    Pender, Barbara
    Shadman, Mazyar
    Hirayama, Alexandre V.
    Till, Brian G.
    Kimble, Erik L.
    Iovino, Lorenzo
    Chapuis, Aude G.
    Otegbeye, Folashade
    Cassaday, Ryan D.
    Milano, Filippo
    Poh, Christina
    Gopal, Ajay K.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2023, 142
12345